Vicarious Surgical Inc. (RBOT): who owns it and who trades it
As of Oct 30, 2026, RBOT insiders reported 6 open-market sales worth $9.6K and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Adam David Sachs (President), with $5.6K.
Latest filing Oct 30, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Insider trades
In the last 12 months, RBOT insiders reported $0 of open-market purchases and $9.6K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Adam David Sachs | President | Sale | 942 | $2.09 | $2K | Form 4 |
| Feb 20, 2026 | Sammy Khalifa | Director | Sale | 754 | $2.08 | $1.6K | Form 4 |
| Dec 3, 2025 | Adam David Sachs | President | Sale | 463 | $2.95 | $1.4K | Form 4 |
| Dec 3, 2025 | Sammy Khalifa | Director | Sale | 239 | $2.97 | $710 | Form 4 |
| Nov 20, 2025 | Sammy Khalifa | Director | Sale | 653 | $2.74 | $1.8K | Form 4 |
| Nov 20, 2025 | Adam David Sachs | President | Sale | 816 | $2.72 | $2.2K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Adam David Sachs | President, Director, 10% owner | – | $5.6K | Feb 20, 2026 |
| Sammy Khalifa | Chief Technology Officer, Director, 10% owner | – | $4.1K | Feb 20, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
RBOT short interest
35,169 RBOT shares are sold short. Over the last 12 reports the number of shares short went down 51%.
As of Oct 30, 2026, 35,169 RBOT shares were sold short, down 44.8% from the report before. At the average daily volume of 68,249 shares, buying them all back would take about 1.0 trading days (days to cover).
Shares short
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 35,169 | – | -45% | 68,249 | 1.0 |
| Oct 15, 2026 | 63,698 | – | -64% | 44,757 | 1.4 |
| Sep 30, 2026 | 175,182 | – | +145% | 164,458 | 1.1 |
| Sep 15, 2026 | 71,545 | – | -27% | 92,023 | 1.0 |
| Aug 31, 2026 | 98,640 | – | -23% | 84,160 | 1.2 |
| Aug 14, 2026 | 127,699 | – | -6% | 31,589 | 4.0 |
| Jul 31, 2026 | 136,441 | – | +8% | 111,783 | 1.2 |
| Jul 15, 2026 | 126,750 | – | +142% | 72,809 | 1.7 |
| Jun 30, 2026 | 52,312 | – | -12% | 129,231 | 1.0 |
| Jun 15, 2026 | 59,645 | – | -17% | 199,604 | 1.0 |
| May 29, 2026 | 71,687 | – | +0% | 47,742 | 1.5 |
| May 15, 2026 | 71,510 | – | -3% | 58,741 | 1.2 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Vicarious Surgical company events
Vicarious Surgical filed 10 reports on Form 8-K in the last 12 months, 7 of them about an important change (leadership, listing). The latest was on Jul 21, 2026.
- Jul 21, 2026LeadershipEach of the members of the Board (Joseph Doherty, Stephen From, Adam Sachs, Sammy Khalifa, David Ho, Victoria Carr-Brendel, and Fuad Ahmad), each provided notice of his or her decision to resign from the Board and all committees thereof, effective upon the filing of the Form 15 with the Securities… Filing
- Jun 24, 2026LeadershipSarah Romano notified the Board of Directors of her resignation as Chief Financial Officer of the Company, effective July 22, 2026, or such later date as may be mutually agreed upon by the Company and Ms. Romano. Filing
- Apr 8, 2026VoteReported shareholder vote results. Filing
- Mar 9, 2026AnnouncementAs previously disclosed, on March 3, 2026, the New York Stock Exchange notified the Company that the NYSE had determined to (A) immediately suspend trading in the Company’s common stock, par value $0.0001 per share, due to a determination that the Company had fallen below the NYSE’s continued… Filing
- Mar 6, 2026LeadershipVicarious Surgical Inc. entered into amendments to the Executive Employment Agreements between the Company and each of Adams Sachs, the President of the Company, and Sammy Khalifa, the Chief Technology Officer of the Company. Filing
- Mar 4, 2026ListingThe New York Stock Exchange notified Vicarious Surgical Inc. that the NYSE had determined to (A) immediately suspend trading in the Company’s common stock, par value $0.0001 per share, due to a determination that the Company had fallen below the NYSE’s continued listing standard requiring listed… Filing
- Feb 2, 2026LeadershipVicarious Surgical Inc. entered into an amendment (the “From Amendment) to the Executive Employment Agreement between the Company and Stephen From, the Chief Executive Officer of the Company. Filing
- Jan 9, 2026VoteReported shareholder vote results. Filing
- Dec 16, 2025ListingThe NYSE notified the Company that the NYSE has determined to (a) commence proceedings to delist the Company’s warrants, with thirty warrants exercisable for one share of Common Stock, at an exercise price of $345.00 per share, and listed to trade on the NYSE under the symbol “RBOT.WS” and (b)… Filing
- Dec 3, 2025LeadershipBeverly Huss and Randy Clark each resigned as a member of the Board of Directors of Vicarious Surgical Inc., effective as of the Effective Date. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Vicarious Surgical financials
Questions about Vicarious Surgical Inc. (RBOT) stock
Are RBOT insiders buying or selling?
In the last 12 months, RBOT insiders reported no open-market purchases and 6 sales worth $9.6K. The latest trade was on Feb 20, 2026. See every trade.
What is the short interest in RBOT?
As of Oct 30, 2026, 35,169 RBOT shares were sold short, down 44.8% from the report before. At the average daily volume of 68,249 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.